Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · Real-Time Price · USD
1.681
-0.050 (-2.85%)
Nov 5, 2024, 11:09 AM EST - Market open
Fortress Biotech Employees
Fortress Biotech had 186 employees as of December 31, 2023. The number of employees decreased by 1 or -0.53% compared to the previous year.
Employees
186
Change (1Y)
-1
Growth (1Y)
-0.53%
Revenue / Employee
$444,215
Profits / Employee
-$264,909
Market Cap
46.32M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Cytosorbents | 186 |
Vicarious Surgical | 131 |
Aadi Bioscience | 89 |
OncoCyte | 46 |
LAVA Therapeutics | 37 |
Envoy Medical | 34 |
Elicio Therapeutics | 32 |
SCYNEXIS | 29 |
FBIO News
- 1 day ago - Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea - GlobeNewsWire
- 11 days ago - Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference - GlobeNewsWire
- 4 weeks ago - Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference - GlobeNewsWire
- 5 weeks ago - Fortress Biotech to Participate in October 2024 Investor Conferences - GlobeNewsWire
- 6 weeks ago - Fortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private Placements - GlobeNewsWire
- 7 weeks ago - Checkpoint Therapeutics Announces Cosibelimab Longer-Term Results in Advanced Cutaneous Squamous Cell Carcinoma Presented at ESMO Congress 2024 - GlobeNewsWire
- 2 months ago - Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference - GlobeNewsWire
- 2 months ago - Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire